WhiteOak Capital Pharma and Healthcare Fund
NAV : ₹ 13.562 as of 16 January, 2026
Overview
₹ 508.73 Cr
Fund size
₹ 100
Min SIP
₹ 500
Lumpsum
16 January 2024
Launch date
Growth
Fund plan
Regular
Scheme type
Return Calculator
₹ 5,000
Over the past
Total Investment of ₹60,000
Monthly SIP of ₹5,000 would have become ₹61,413 in 1 year with a gain of ₹1,413 (+2.30%)
Disclaimer: Past performance is not an indicator of future returns
Top Holdings
Sun Pharmaceutical Industries Ltd. | 10.91% |
JB Chemicals & Pharmaceuticals Ltd. | 8.38% |
Max Healthcare Institute Ltd. | 6.90% |
Laurus Labs Ltd. | 5.44% |
Fortis Healthcare Ltd. | 5.25% |
Equity Holding(s) Distribution
Other Scheme Info
Expense Ratio
Inclusive of GST
2.37%
Stamp Duty
0.005%
Exit Load
Exit load of 1%, if redeemed within 1 months.
0
View Scheme Document
Peer Analysis
View more
Compare Funds
Compare with other funds
WhiteOak Capital Pharma and Healthcare Fund Managers
List of WhiteOak Capital Mutual Fund's top performing schemes
25.26% | |
19.29% | |
17.45% | |
Fund House
WhiteOak Capital Mutual Fund
Total AUM: 30843.33Cr
WhiteOak Capital Mutual Fund is overseen by WhiteOak Capital Asset Management Limited, a division of the White Oak Capital Group. Founded in June 2017 under the guidance of Mr. Prashant Khemka, White Oak has garnered substantial Foreign Portfolio Investment inflows into India over the past three years. The firm operates in multiple locations, including India, Singapore, Mauritius, the United Kingdom, and Switzerland. As of November 2025, the Assets Under Management (AUM) of the fund house amounted to Rs. 30,843.32 crores.
Learn more about WhiteOak Capital Mutual Fund
Kotak Neo: AMFI-registered Mutual Fund Distributor
FAQ for WhiteOak Capital Pharma and Healthcare Fund
Start SIP with just Rs.100
Start SIP with just Rs.100